DTC Limits May Land In Court After Opponents Fail To Strip FDA Powers From Bill

The restrictions on direct-to-consumer advertising placed in the legislation to renew the prescription drug user fee program appear headed towards a showdown in the judicial branch after an attempt to remove them failed in a Senate committee

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet